Stuart Laermer
Corporate Officer/Principal bei Fisher Scientific Canada
Profil
Stuart Laermer is currently the Director of Biotechnology & Specialty Products at Fisher Scientific Canada.
Previously, he worked as the Director of Business Development at Hoffmann-La Roche, Inc., Vice President of Business Development at Synthon Chiragenics Corp., and Chief Business Officer at Oxurion NV.
Mr. Laermer has a graduate degree from The Trustees of Columbia University in The City of New York and an MBA from New York University.
Aktive Positionen von Stuart Laermer
| Unternehmen | Position | Beginn |
|---|---|---|
| Fisher Scientific Canada | Corporate Officer/Principal | 19.08.2010 |
Ehemalige bekannte Positionen von Stuart Laermer
| Unternehmen | Position | Ende |
|---|---|---|
| OXURION NV | Corporate Officer/Principal | 01.01.2013 |
Synthon Chiragenics Corp.
 Synthon Chiragenics Corp. Pharmaceuticals: MajorHealth Technology Synthon Chiragenics Corp. researches and develops carbohydrate-based pharmaceuticals. The company is headquartered in Monmouth Junction, NJ. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Direktor/Vorstandsmitglied | 07.01.2011 |
Ausbildung von Stuart Laermer
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| New York University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXURION NV | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Synthon Chiragenics Corp.
Synthon Chiragenics Corp. Pharmaceuticals: MajorHealth Technology Synthon Chiragenics Corp. researches and develops carbohydrate-based pharmaceuticals. The company is headquartered in Monmouth Junction, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| Fisher Scientific Canada |
